SynuCa Therapeutics
Copenhagen, Denmark· Est.
SynuCa Therapeutics develops small molecule drugs targeting protein degradation for cancer and neurodegenerative diseases.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
About
SynuCa Therapeutics develops small molecule drugs targeting protein degradation for cancer and neurodegenerative diseases.
Small MoleculesOncologyNeuroscience